Achieve Life Sciences Inc
F:SP4P
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Achieve Life Sciences Inc
F:SP4P
|
US |
|
C
|
Central Japan Railway Co
F:JAP
|
JP |
|
K
|
Kopin Corp
F:KOC
|
US |
|
C
|
Cosmo Metals Ltd
ASX:CMO
|
AU |
|
Anima Holding SpA
MIL:ANIM
|
IT |
|
K
|
Kopin Corp
XMUN:KOC
|
US |
Intrinsic Value
Is SP4P undervalued or overvalued?
See the intrinsic value estimate for 
Achieve Life Sciences Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
SP4P looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with SP4P’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Achieve Life Sciences Does
Achieve Life Sciences is a biopharmaceutical company focused on developing treatments for nicotine dependence and smoking cessation. Its lead drug candidate is cytisinicline, an oral medicine designed to help adults quit smoking and vaping by reducing cravings and withdrawal symptoms.
- Headquarters
- United States of America US
- Employees
- 28
- IPO date
- Oct 12, 1995
Revenue & Expenses Breakdown
Achieve Life Sciences Inc
Earnings Waterfall
Achieve Life Sciences Inc
The intrinsic value for Achieve Life Sciences Inc (SP4P) under the Base Case is hidden EUR.
Compared with the current market price of 5.7 EUR, the stock appears hidden.